wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41980844-3B1C4025-9B1E-4824-9F57-E7B60A7D1CE7
Q41980844-3B1C4025-9B1E-4824-9F57-E7B60A7D1CE7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41980844-3B1C4025-9B1E-4824-9F57-E7B60A7D1CE7
BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.
P2860
Q41980844-3B1C4025-9B1E-4824-9F57-E7B60A7D1CE7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41980844-3B1C4025-9B1E-4824-9F57-E7B60A7D1CE7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
09d6721e8b14fc30433bfedf36fc13bfee1b7e24
P2860
AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance